Clinical Trials Directory

Trials / Completed

CompletedNCT03219229

Metabolic Effects of Differential Organ Growth Rates

Status
Completed
Phase
Study type
Observational
Enrollment
49 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
7 Years – 11 Years
Healthy volunteers
Accepted

Summary

Young children have a high resting energy expenditure (REE) relative to their body weight and metabolically active compartment, fat-free mass (FFM). Both body weight and FFM are, however, metabolically heterogeneous and include organs and tissues varying widely in specific metabolic rate (i.e., organ REE/kg/d). One prevailing hypothesis is that most, if not all, of the higher REE observed in young animals and children compared to adults can be accounted for by a larger proportion of high metabolic rate components such as brain, liver, and heart..

Detailed description

FFM was the traditional and only means of adjusting REE for between-individual differences in metabolically active tissue components. The investigators seek to improve the understanding of variation in REE by developing new and improved rapid magnetic resonance imaging (MRI) methods of quantifying some of the major heat producing organs and tissues in children and adults. The long-term aim is to provide an improved understanding of human energy requirements. Specifically, the investigators propose to test whether: 1) a portion of the elevated daily REE adjusted for FFM observed in young children (Tanner Stage 1) could be accounted for by the relative fractions of body mass as high metabolic activity tissues (heart, liver, kidney, brain) and low metabolic activity tissues (skeletal muscle, adipose tissue), 2) a portion of the age-related decline in daily REE adjusted for FFM observed in children could be accounted for by changes in the relative fractions of body mass as high and low metabolic rate tissues during growth.

Conditions

Timeline

Start date
2004-02-14
Primary completion
2007-02-20
Completion
2007-02-20
First posted
2017-07-17
Last updated
2017-07-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03219229. Inclusion in this directory is not an endorsement.